BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 27121275)

  • 1. Identification of MAC1: A Small Molecule That Rescues Spindle Bipolarity in Monastrol-Treated Cells.
    Al-Obaidi N; Mitchison TJ; Crews CM; Mayer TU
    ACS Chem Biol; 2016 Jun; 11(6):1544-51. PubMed ID: 27121275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New chemical tools for investigating human mitotic kinesin Eg5.
    Klein E; DeBonis S; Thiede B; Skoufias DA; Kozielski F; Lebeau L
    Bioorg Med Chem; 2007 Oct; 15(19):6474-88. PubMed ID: 17587586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of the mitotic kinesin Eg5 inhibitor monastrol with P-glycoprotein.
    Peters T; Lindenmaier H; Haefeli WE; Weiss J
    Naunyn Schmiedebergs Arch Pharmacol; 2006 Jan; 372(4):291-9. PubMed ID: 16365780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probing spindle assembly mechanisms with monastrol, a small molecule inhibitor of the mitotic kinesin, Eg5.
    Kapoor TM; Mayer TU; Coughlin ML; Mitchison TJ
    J Cell Biol; 2000 Sep; 150(5):975-88. PubMed ID: 10973989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monastrol inhibition of the mitotic kinesin Eg5.
    Cochran JC; Gatial JE; Kapoor TM; Gilbert SP
    J Biol Chem; 2005 Apr; 280(13):12658-67. PubMed ID: 15665380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of the mitotic inhibitor monastrol with human kinesin Eg5.
    DeBonis S; Simorre JP; Crevel I; Lebeau L; Skoufias DA; Blangy A; Ebel C; Gans P; Cross R; Hackney DD; Wade RH; Kozielski F
    Biochemistry; 2003 Jan; 42(2):338-49. PubMed ID: 12525161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small molecule inhibitor of mitotic spindle bipolarity identified in a phenotype-based screen.
    Mayer TU; Kapoor TM; Haggarty SJ; King RW; Schreiber SL; Mitchison TJ
    Science; 1999 Oct; 286(5441):971-4. PubMed ID: 10542155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of apoptosis by monastrol, an inhibitor of the mitotic kinesin Eg5, is independent of the spindle checkpoint.
    Chin GM; Herbst R
    Mol Cancer Ther; 2006 Oct; 5(10):2580-91. PubMed ID: 17041103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Kinesin-14 leaps to pole position in bipolar spindle assembly].
    Paluh JL
    Ai Zheng; 2008 Sep; 27(9):989-92. PubMed ID: 18799042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allosteric inhibition of kinesin-5 modulates its processive directional motility.
    Kwok BH; Kapitein LC; Kim JH; Peterman EJ; Schmidt CF; Kapoor TM
    Nat Chem Biol; 2006 Sep; 2(9):480-5. PubMed ID: 16892050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular dissection of the inhibitor binding pocket of mitotic kinesin Eg5 reveals mutants that confer resistance to antimitotic agents.
    Brier S; Lemaire D; DeBonis S; Forest E; Kozielski F
    J Mol Biol; 2006 Jul; 360(2):360-76. PubMed ID: 16780877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure of human Eg5 in complex with a new monastrol-based inhibitor bound in the R configuration.
    Garcia-Saez I; DeBonis S; Lopez R; Trucco F; Rousseau B; Thuéry P; Kozielski F
    J Biol Chem; 2007 Mar; 282(13):9740-9747. PubMed ID: 17251189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of inhibition of human KSP by monastrol: insights from kinetic analysis and the effect of ionic strength on KSP inhibition.
    Luo L; Carson JD; Dhanak D; Jackson JR; Huang PS; Lee Y; Sakowicz R; Copeland RA
    Biochemistry; 2004 Dec; 43(48):15258-66. PubMed ID: 15568818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interplay of microtubule dynamics and sliding during bipolar spindle formation in mammalian cells.
    Kollu S; Bakhoum SF; Compton DA
    Curr Biol; 2009 Dec; 19(24):2108-13. PubMed ID: 19931454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence that monastrol is an allosteric inhibitor of the mitotic kinesin Eg5.
    Maliga Z; Kapoor TM; Mitchison TJ
    Chem Biol; 2002 Sep; 9(9):989-96. PubMed ID: 12323373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological evaluation of novel EG5 inhibitors.
    Sarli V; Huemmer S; Sunder-Plassmann N; Mayer TU; Giannis A
    Chembiochem; 2005 Nov; 6(11):2005-13. PubMed ID: 16216042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitors of kinesin Eg5: antiproliferative activity of monastrol analogues against human glioblastoma cells.
    Müller C; Gross D; Sarli V; Gartner M; Giannis A; Bernhardt G; Buschauer A
    Cancer Chemother Pharmacol; 2007 Feb; 59(2):157-64. PubMed ID: 16703323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NSC 622124 inhibits human Eg5 and other kinesins via interaction with the conserved microtubule-binding site.
    Learman SS; Kim CD; Stevens NS; Kim S; Wojcik EJ; Walker RA
    Biochemistry; 2009 Mar; 48(8):1754-62. PubMed ID: 19236100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural basis for inhibition of Eg5 by dihydropyrimidines: stereoselectivity of antimitotic inhibitors enastron, dimethylenastron and fluorastrol.
    Kaan HY; Ulaganathan V; Rath O; Prokopcová H; Dallinger D; Kappe CO; Kozielski F
    J Med Chem; 2010 Aug; 53(15):5676-83. PubMed ID: 20597485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A structural model for monastrol inhibition of dimeric kinesin Eg5.
    Krzysiak TC; Wendt T; Sproul LR; Tittmann P; Gross H; Gilbert SP; Hoenger A
    EMBO J; 2006 May; 25(10):2263-73. PubMed ID: 16642039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.